Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,781 | 395 | 99.9% |
| Education | $8.35 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $866.08 | 59 | $0 (2024) |
| Novo Nordisk Inc | $811.13 | 83 | $0 (2024) |
| Lilly USA, LLC | $456.49 | 36 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $352.69 | 19 | $0 (2024) |
| Amgen Inc. | $295.43 | 21 | $0 (2024) |
| Merck Sharp & Dohme LLC | $288.21 | 20 | $0 (2024) |
| PFIZER INC. | $235.77 | 14 | $0 (2024) |
| Radius Health, Inc. | $230.06 | 13 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $206.90 | 13 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $175.87 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $890.19 | 44 | ABBVIE INC. ($267.66) |
| 2023 | $662.68 | 39 | AbbVie Inc. ($166.80) |
| 2022 | $666.85 | 47 | Novo Nordisk Inc ($135.99) |
| 2021 | $728.32 | 49 | AbbVie Inc. ($178.66) |
| 2020 | $322.27 | 21 | AbbVie Inc. ($60.78) |
| 2019 | $792.62 | 60 | PFIZER INC. ($133.55) |
| 2018 | $761.69 | 64 | Novo Nordisk Inc ($113.33) |
| 2017 | $964.40 | 72 | Novo Nordisk Inc ($201.72) |
All Payment Transactions
396 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/08/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 10/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.17 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: Cardio-renal | ||||||
| 10/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: Diabetes | ||||||
| 09/30/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/12/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: NEUROSCIENCE | ||||||
| 09/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: NEUROSCIENCE | ||||||
| 09/09/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: VACCINE | ||||||
| 09/06/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $10.08 | General |
| Category: NEUROSCIENCE | ||||||
| 08/26/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.27 | General |
| Category: Cardiovascular | ||||||
| 08/19/2024 | Hologic Sales and Service, LLC | APTIMA (Device) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Diagnostics | ||||||
| 08/09/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Bone Health | ||||||
| 08/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: RESPIRATORY | ||||||
| 07/19/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: Diabetes | ||||||
| 07/12/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: NEUROSCIENCE | ||||||
| 07/08/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Gastroenterology | ||||||
| 06/24/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: Respiratory | ||||||
| 06/13/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Diabetes | ||||||
| 06/08/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Biological | ||||||
| 05/22/2024 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: Diabetes Care | ||||||
| 05/20/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: Oncology | ||||||
| 05/13/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: NEUROSCIENCE | ||||||
| 05/10/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: Diabetes | ||||||
| 04/29/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 362 | 596 | $58,165 | $33,651 |
| 2022 | 15 | 513 | 841 | $74,945 | $40,677 |
| 2021 | 15 | 550 | 995 | $78,915 | $41,671 |
| 2020 | 15 | 507 | 925 | $72,435 | $35,452 |
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 101 | 236 | $33,040 | $20,046 | 60.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 61 | 95 | $10,925 | $6,034 | 55.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 19 | 19 | $3,420 | $2,382 | 69.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 46 | 57 | $3,990 | $2,005 | 50.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 30 | 30 | $1,050 | $880.80 | 83.9% |
| 20605 | Aspiration and/or injection of fluid from medium joint | Office | 2023 | 11 | 19 | $1,520 | $762.03 | 50.1% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 32 | 32 | $1,280 | $654.72 | 51.2% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 11 | 11 | $825.00 | $446.05 | 54.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 25 | 37 | $1,295 | $352.24 | 27.2% |
| 81002 | Urinalysis, manual test | Office | 2023 | 14 | 16 | $160.00 | $54.56 | 34.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 12 | 44 | $660.00 | $32.76 | 5.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 113 | 225 | $31,500 | $18,494 | 58.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 79 | 126 | $14,490 | $7,744 | 53.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 32 | 32 | $5,760 | $4,049 | 70.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 70 | 111 | $7,770 | $3,888 | 50.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 13 | 13 | $2,600 | $1,574 | 60.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 12 | 32 | $3,200 | $1,127 | 35.2% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 22 | 22 | $1,650 | $886.94 | 53.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 30 | 30 | $1,050 | $838.50 | 79.9% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2022 | 31 | 31 | $1,240 | $622.17 | 50.2% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 37 | 57 | $1,995 | $546.46 | 27.4% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 13 | 26 | $910.00 | $427.99 | 47.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 11 | 23 | $805.00 | $196.40 | 24.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 18 | 19 | $665.00 | $152.84 | 23.0% |
| 81002 | Urinalysis, manual test | Office | 2022 | 18 | 20 | $200.00 | $68.84 | 34.4% |
About Dr. Dana Bonezzi, MD
Dr. Dana Bonezzi, MD is a Internal Medicine healthcare provider based in Wooster, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1255331542.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dana Bonezzi, MD has received a total of $5,789 in payments from pharmaceutical and medical device companies, with $890.19 received in 2024. These payments were reported across 396 transactions from 50 companies. The most common payment nature is "Food and Beverage" ($5,781).
As a Medicare-enrolled provider, Bonezzi has provided services to 1,932 Medicare beneficiaries, totaling 3,357 services with total Medicare billing of $151,451. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Wooster, OH
- Active Since 07/28/2005
- Last Updated 04/01/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1255331542
Products in Payments
- Ozempic (Drug) $352.55
- UBRELVY (Drug) $317.78
- JARDIANCE (Drug) $255.71
- FARXIGA (Drug) $241.02
- XIFAXAN (Drug) $231.78
- VRAYLAR (Drug) $209.72
- Victoza (Drug) $204.93
- MOUNJARO (Drug) $179.71
- ELIQUIS (Drug) $167.65
- AFREZZA (Drug) $147.31
- Tymlos (Drug) $129.05
- JANUVIA (Drug) $123.28
- QULIPTA (Drug) $103.65
- Tymlos (Biological) $101.01
- TRINTELLIX (Drug) $96.31
- VYNDAQEL (Drug) $93.20
- Kerendia (Drug) $92.53
- Vascepa (Drug) $87.89
- Prolia (Biological) $86.94
- EMGALITY (Drug) $80.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Wooster
Debra Fast, Do, DO
Internal Medicine — Payments: $9,973
Kathleen Fearon, Do, DO
Internal Medicine — Payments: $8,946
Alycia Findlay, M.d, M.D
Internal Medicine — Payments: $1,654
Ruta Semaskiene, Md, MD
Internal Medicine — Payments: $543.63
Loren Kirchner, Md, MD
Internal Medicine — Payments: $329.71
Mrs. Rosa Cleaver, Aprn, Fnp-C, APRN, FNP-C
Internal Medicine — Payments: $292.31